Xiao Lei Gu
Director of Finance/CFO chez BBI LIFE SCIENCES CORPORATION
Profil
Xiao Lei Gu is currently the Chief Financial Officer at BBI Life Sciences Corp.
since 2015.
Prior to this, he obtained an undergraduate degree from Shanghai University of Finance & Economics.
Postes actifs de Xiao Lei Gu
| Sociétés | Poste | Début |
|---|---|---|
| BBI LIFE SCIENCES CORPORATION | Director of Finance/CFO | 11/09/2015 |
Formation de Xiao Lei Gu
| Shanghai University of Finance & Economics | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
BBI Life Sciences Corp.
 BBI Life Sciences Corp. BiotechnologyHealth Technology BBI Life Sciences Corp. is an investment holding company that engages in the development, manufacture, and sale of various life sciences products used in scientific research. The firm also provides life sciences related services. It operates through the following segments: DNA Synthesis Products, Genetic Engineering Services, Life Sciences Research Consumables, and Protein and Antibody Related Products and Services. The DNA Synthesis Products segment comprises of oligonucleotide synthesis and gene synthesis. The Genetic Engineering Services segment includes DNA sequencing, next generation sequencing, and molecular biology services. The Life Sciences Research Consumables segment refers to experimental materials, such as biochemical reagents, and research kits and consumable parts for experiments. The Protein and Antibody Related Products and Services segment involves protein and antibody related products used for immunology experiments. The company was founded on July 10, 2013 and is headquartered in Shanghai, China. | Health Technology |
